How I Treat Relapsed Myeloma
S. Vincent Rajkumar, MD, Mayo Clinic
Saturday, September 9, 2017 3:00 p.m.
Fairmont Chicago, Millennium Park, Chicago, IL
Almost all patients with myeloma relapse, and there are multiple new options to treat patients with relapsed myeloma. Multiple factors need to be considered in determining the specific treatment for each patient at the time of relapse. This includes factors such as risk stratification, speed and aggressiveness of the relapse, nature and response to prior therapy, and eligibility for stem cell transplant. Dr. Rajkumar will review the various new treatments for relapsed myeloma including monoclonal antibodies, newer proteasome inhibitors, and other active regimens. He will provide a clear practical algorithm for treatment of first and subsequent relapses.
About the Speaker
S. Vincent Rajkumar, MD, is Edward W. and Betty Knight Scripps Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He chairs the Eastern Cooperative Oncology Group Myeloma Committee. Dr. Rajkumar has published more than 300 peer-reviewed research papers. He serves as the Section Editor for Leukemia, Associate Editor for Mayo Clinic Proceedings and the European Journal of Haematology, and Editor-in-Chief of Blood Cancer Journal. He is the recipient of the Robert A. Kyle Lifetime Achievement Award from the International Myeloma Foundation.
back to top